These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10958750)

  • 21. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic evaluation of patients with urinary system stone disease: a research of pediatric and adult patients.
    Oğuz U; Resorlu B; Unsal A
    Int Urol Nephrol; 2014 Feb; 46(2):329-34. PubMed ID: 23975676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stone formation in patients less than 20 years of age is associated with higher rates of stone recurrence: Results from the Registry for Stones of the Kidney and Ureter (ReSKU).
    Li Y; Bayne D; Wiener S; Ahn J; Stoller M; Chi T
    J Pediatr Urol; 2020 Jun; 16(3):373.e1-373.e6. PubMed ID: 32280060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.
    Lee YH; Huang WC; Tsai JY; Huang JK
    J Urol; 1999 May; 161(5):1453-7. PubMed ID: 10210371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stone recurrence predictive score (SRPS) for patients with calcium oxalate stones.
    Lee YH; Huang WC; Lu CM; Tsai JY; Huang JK
    J Urol; 2003 Aug; 170(2 Pt 1):404-7. PubMed ID: 12853786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dietary modification on urinary stone risk factors.
    Pak CY; Odvina CV; Pearle MS; Sakhaee K; Peterson RD; Poindexter JR; Brinkley LJ
    Kidney Int; 2005 Nov; 68(5):2264-73. PubMed ID: 16221228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical observations on 2086 patients with upper urinary tract stone.
    Trinchieri A; Rovera F; Nespoli R; Currò A
    Arch Ital Urol Androl; 1996 Sep; 68(4):251-62. PubMed ID: 8936717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential surgical implications of unexplained hematuria in children.
    Noe HN; Stapleton FB; Roy S
    J Urol; 1984 Oct; 132(4):737-8. PubMed ID: 6471221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
    Ala-Opas M; Elomaa I; Porkka L; Alfthan O
    Scand J Urol Nephrol; 1987; 21(4):311-4. PubMed ID: 2832935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary interventions for preventing complications in idiopathic hypercalciuria.
    Escribano J; Balaguer A; Roqué i Figuls M; Feliu A; Ferre N
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD006022. PubMed ID: 24519664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of elevated urinary cadmium with urinary stone, hypercalciuria and renal tubular dysfunction in the population of cadmium-contaminated area.
    Kaewnate Y; Niyomtam S; Tangvarasittichai O; Meemark S; Pingmuangkaew P; Tangvarasittichai S
    Bull Environ Contam Toxicol; 2012 Dec; 89(6):1120-4. PubMed ID: 23064446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.